{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:06:50Z","timestamp":1790237210476,"version":"4.1.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T00:00:00Z","timestamp":1665964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020YFC2005501 2020YFC2005503"],"award-info":[{"award-number":["2020YFC2005501 2020YFC2005503"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012401","name":"Beijing Science and Technology Planning Project","doi-asserted-by":"publisher","award":["Z201100005620006"],"award-info":[{"award-number":["Z201100005620006"]}],"id":[{"id":"10.13039\/501100012401","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Valproic acid\/sodium valproate (VPA) is a widely used anticonvulsant drug for maintenance treatment of bipolar disorders. In order to balance the efficacy and adverse events of VPA treatment, an individualized dose regimen is necessary. This study aimed to establish an individualized medication model of VPA for patients with bipolar disorder based on machine learning and deep learning techniques. The sequential forward selection (SFS) algorithm was applied for selecting a feature subset, and random forest was used for interpolating missing values. Then, we compared nine models using XGBoost, LightGBM, CatBoost, random forest, GBDT, SVM, logistic regression, ANN, and TabNet, and CatBoost was chosen to establish the individualized medication model with the best performance (accuracy = 0.85, AUC = 0.91, sensitivity = 0.85, and specificity = 0.83). Three important variables that correlated with VPA daily dose included VPA TDM value, antipsychotics, and indirect bilirubin. SHapley Additive exPlanations was applied to visually interpret their impacts on VPA daily dose. Last, the confusion matrix presented that predicting a daily dose of 0.5\u00a0g VPA had a precision of 55.56% and recall rate of 83.33%, and predicting a daily dose of 1\u00a0g VPA had a precision of 95.83% and a recall rate of 85.19%. In conclusion, the individualized medication model of VPA for patients with bipolar disorder based on CatBoost had a good prediction ability, which provides guidance for clinicians to propose the optimal medication regimen.<\/jats:p>","DOI":"10.3389\/fphar.2022.890221","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T04:58:30Z","timestamp":1665982710000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["An individualized medication model of sodium valproate for patients with bipolar disorder based on machine learning and deep learning techniques"],"prefix":"10.3389","volume":"13","author":[{"given":"Ping","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqian","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunming","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2165\/00002018-200629020-00001","article-title":"Interactions between antiepileptic and antipsychotic drugs","volume":"29","author":"Besag","year":"2006","journal-title":"Drug Saf."},{"key":"B2","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1080\/j.1440-1614.2006.01815.x","article-title":"Anticonvulsants in bipolar disorder","volume":"40","author":"Bowden","year":"2006","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/sj.npp.1300023","article-title":"Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia","volume":"28","author":"Casey","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"479364","DOI":"10.1155\/2010\/479364","article-title":"Molecular and therapeutic potential and toxicity of valproic acid","volume":"2010","author":"Chateauvieux","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1613\/jair.953","article-title":"Smote: Synthetic minority over-sampling technique","volume":"16","author":"Chawla","year":"2002","journal-title":"J. Artif. Intell. Res."},{"key":"B6","first-page":"785","article-title":"XGBoost: A scalable tree boosting system","author":"Chen","year":"2016"},{"key":"B7","doi-asserted-by":"publisher","first-page":"CD003196","DOI":"10.1002\/14651858.CD003196.pub2","article-title":"Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder","volume":"2013","author":"Cipriani","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.jad.2019.08.071","article-title":"Intravenous valproate in the treatment of acute manic episode in bipolar disorder: A review","volume":"260","author":"Fontana","year":"2020","journal-title":"J. Affect. Disord."},{"key":"B9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s40537-020-00369-8","article-title":"CatBoost for big data: An interdisciplinary review","volume":"7","author":"Hancock","year":"2020","journal-title":"J. Big Data"},{"key":"B10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4103\/2228-7477.137777","article-title":"The emotion recognition system based on autoregressive model and sequential forward feature selection of electroencephalogram signals","volume":"4","author":"Hatamikia","year":"2014","journal-title":"J. Med. Signals Sens."},{"key":"B11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/FTD.0b013e3181c13a30","article-title":"Does valproic acid warrant therapeutic drug monitoring in bipolar affective disorder?","volume":"32","author":"Haymond","year":"2010","journal-title":"Ther. Drug Monit."},{"key":"B12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1055\/s-0031-1286287","article-title":"AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: Update 2011","volume":"44","author":"Hiemke","year":"2011","journal-title":"Pharmacopsychiatry"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1055\/s-0037-1600991","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: Update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"B14","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1080\/17512433.2021.1911642","article-title":"Prediction of vancomycin dose on high-dimensional data using machine learning techniques","volume":"14","author":"Huang","year":"2021","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"B15","first-page":"3146","article-title":"A highly efficient gradient boosting decision tree","volume-title":"Proceedings of the advances in neural information processing systems","author":"Ke","year":"2017"},{"key":"B16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/toxsci\/kfl096","article-title":"Contribution of CYP2C9, CYP2A6, and CYP2B6 to valproic acid metabolism in hepatic microsomes from individuals with the CYP2C9*1\/*1 genotype","volume":"94","author":"Kiang","year":"2006","journal-title":"Toxicol. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e10337","DOI":"10.1002\/jbm4.10337","article-title":"A novel fracture prediction model using machine learning in a community-based cohort","volume":"4","author":"Kong","year":"2020","journal-title":"JBMR Plus"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1007\/s00439-012-1194-y","article-title":"Risk estimation and risk prediction using machine-learning methods","volume":"131","author":"Kruppa","year":"2012","journal-title":"Hum. Genet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3390\/jcm7110428","article-title":"Prediction of acute kidney injury after liver transplantation: Machine learning approaches vs. Logistic regression model","volume":"7","author":"Lee","year":"2018","journal-title":"J. Clin. Med."},{"key":"B20","first-page":"780","article-title":"Valproic acid: Chemistry, biotransformation and pharmacokinetics","volume-title":"Antiepileptic drugs","author":"Levy","year":"2002"},{"key":"B21","doi-asserted-by":"publisher","first-page":"104242","DOI":"10.1016\/j.compbiomed.2021.104242","article-title":"An ensemble learning based framework to estimate warfarin maintenance dose with cross-over variables exploration on incomplete data set","volume":"131","author":"Liu","year":"2021","journal-title":"Comput. Biol. Med."},{"key":"B22","first-page":"4765","article-title":"A unified approach to interpreting model predictions","volume-title":"Advances in neural information processing systems","author":"Lundberg","year":"2017"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.3389\/fphar.2019.01155","article-title":"Early and accurate prediction of clinical response to methotrexate treatment in juvenile idiopathic arthritis using machine learning","volume":"10","author":"Mo","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2174\/1570159X15666171109143654","article-title":"Relevance of CYP2C9 function in valproate therapy","volume":"17","author":"Monostory","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/00002826-200209000-00012","article-title":"Antiepileptic-antipsychotic drug interactions: A critical review of the evidence","volume":"25","author":"Mula","year":"2002","journal-title":"Clin. Neuropharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/FTD.0000000000000546","article-title":"Therapeutic drug monitoring of antiepileptic drugs in epilepsy: A 2018 update","volume":"40","author":"Patsalos","year":"2018","journal-title":"Ther. Drug Monit."},{"key":"B27","doi-asserted-by":"publisher","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of valproate: A summary after 35 years of clinical experience","volume":"16","author":"Perucca","year":"2002","journal-title":"CNS Drugs"},{"key":"B28","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s40291-018-0335-y","article-title":"The role of pharmacogenomics in bipolar disorder: Moving towards precision medicine","volume":"22","author":"Pisanu","year":"2018","journal-title":"Mol. Diagn. Ther."},{"key":"B29","article-title":"Catboost: Unbiased boosting with categorical features","author":"Prokhorenkova","year":"2017"},{"key":"B30","first-page":"698","article-title":"Human CYP2C9 and CYP2A6 mediate formation of the hepatotoxin 4-ene-valproic acid","volume":"283","author":"Sadeque","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10545-008-0841-x","article-title":"Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: A review","volume":"31","author":"Silva","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.phrs.2016.02.014","article-title":"Clinically significant pharmacokinetic drug interactions of antiepileptic drugs with new antidepressants and new antipsychotics","volume":"106","author":"Spina","year":"2016","journal-title":"Pharmacol. Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/epi.12109","article-title":"Antiepileptic drug treatment in pregnancy: Changes in drug disposition and their clinical implications","volume":"54","author":"Tomson","year":"2013","journal-title":"Epilepsia"},{"key":"B34","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1097\/00004583-200108000-00003","article-title":"Valproic acid and risperidone","volume":"40","author":"van Wattum","year":"2001","journal-title":"J. Am. Acad. Child. Adolesc. Psychiatry"},{"key":"B35","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1097\/s0890-8567(09)60329-4","article-title":"Valproic acid and risperidone: Commentary","volume":"40","author":"Vitiello","year":"2001","journal-title":"J. Am. Acad. Child. Adolesc. Psychiatry"},{"key":"B36","doi-asserted-by":"publisher","first-page":"CD004028","DOI":"10.1002\/14651858.CD004028.pub2","article-title":"Valproate for schizophrenia","volume":"11","author":"Wang","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"B37","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1021\/acs.jcim.9b00633","article-title":"LightGBM: An effective and scalable algorithm for prediction of chemical toxicity-application to the Tox21 and mutagenicity data sets","volume":"59","author":"Zhang","year":"2019","journal-title":"J. Chem. Inf. Model."},{"key":"B38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000504645","article-title":"An epileptic patient with recurrent hyperbilirubinemia caused by gilbert syndrome","volume":"14","author":"Zhang","year":"2020","journal-title":"Case Rep. Gastroenterol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.890221\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T10:46:07Z","timestamp":1666176367000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.890221\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,17]]},"references-count":38,"alternative-id":["10.3389\/fphar.2022.890221"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.890221","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,17]]},"article-number":"890221"}}